These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. An adolescent with abdominal pain taking isotretinoin for severe acne. Greene JP South Med J; 2006 Sep; 99(9):992-4. PubMed ID: 17004534 [TBL] [Abstract][Full Text] [Related]
25. Eruptive milia during isotretinoin therapy. Farmer W; Cheng K; Marathe K Pediatr Dermatol; 2017 Nov; 34(6):728-729. PubMed ID: 28940619 [TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin. Yook JH; Han JY; Choi JS; Ahn HK; Lee SW; Kim MY; Ryu HM; Nava-Ocampo AA Clin Toxicol (Phila); 2012 Dec; 50(10):896-901. PubMed ID: 23116253 [TBL] [Abstract][Full Text] [Related]
27. Isotretinoin embryopathy and the cranial neural crest: an in vivo and in vitro study. Webster WS; Johnston MC; Lammer EJ; Sulik KK J Craniofac Genet Dev Biol; 1986; 6(3):211-22. PubMed ID: 3464614 [TBL] [Abstract][Full Text] [Related]
28. Retinoic acid embryopathy: case report and review of literature. Coberly S; Lammer E; Alashari M Pediatr Pathol Lab Med; 1996; 16(5):823-36. PubMed ID: 9025880 [TBL] [Abstract][Full Text] [Related]
31. Safety of pregnancy after discontinuation of isotretinoin. Dai WS; Hsu MA; Itri LM Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442 [TBL] [Abstract][Full Text] [Related]
32. Development of canal cholesteatoma in a patient with prenatal isotretinoin exposure. Van Abel KM; Nelson ME; Collar RM; Lesperance MM Int J Pediatr Otorhinolaryngol; 2010 Sep; 74(9):1082-4. PubMed ID: 20638138 [TBL] [Abstract][Full Text] [Related]
33. Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne. Tekin NS; Ozdolap S; Sarikaya S; Keskin SI Int J Dermatol; 2008 Jun; 47(6):622-5. PubMed ID: 18477161 [TBL] [Abstract][Full Text] [Related]
34. When a uniquely effective drug is teratogenic. The case of isotretinoin. Stern RS N Engl J Med; 1989 Apr; 320(15):1007-9. PubMed ID: 2522591 [No Abstract] [Full Text] [Related]
35. [Teratogenicity of retinoids. A case and review of the literature]. Heckel S; Favre R; Weber P; Dellenbach P J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):43-7. PubMed ID: 8463566 [TBL] [Abstract][Full Text] [Related]
36. Safety issues in isotretinoin therapy. Hanson N; Leachman S Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672 [TBL] [Abstract][Full Text] [Related]
37. Retinoic Acid Embryopathy. Mondal D; R Shenoy S; Mishra S Int J Appl Basic Med Res; 2017; 7(4):264-265. PubMed ID: 29308367 [TBL] [Abstract][Full Text] [Related]
39. The effects of microduplication 1q21.1 and in-utero isotretinoin exposure. Taylor SK; Toko R BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29103005 [TBL] [Abstract][Full Text] [Related]
40. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster. Atanackovic G; Koren G Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]